Empar Sáinz

495 total citations
7 papers, 138 citations indexed

About

Empar Sáinz is a scholar working on Infectious Diseases, Epidemiology and Genetics. According to data from OpenAlex, Empar Sáinz has authored 7 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Empar Sáinz's work include Inflammatory Bowel Disease (3 papers), Microscopic Colitis (3 papers) and Amoebic Infections and Treatments (2 papers). Empar Sáinz is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Microscopic Colitis (3 papers) and Amoebic Infections and Treatments (2 papers). Empar Sáinz collaborates with scholars based in Spain. Empar Sáinz's co-authors include Fernando Fernández‐Bañares, María Esteve, Elena Pérez Rodríguez, Uma Mahadevan, Antonio Salas, Carme Loras, Mercè Rosinach, Montserrat Forné, Josep Maria Viver and Victòria Gonzalo and has published in prestigious journals such as Journal of Crohn s and Colitis, Digestive and Liver Disease and Revista Española de Enfermedades Digestivas.

In The Last Decade

Empar Sáinz

7 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Empar Sáinz Spain 5 108 60 52 38 32 7 138
Mercè Navarro‐Llavat Spain 5 39 0.4× 55 0.9× 3 0.1× 8 0.2× 45 1.4× 6 118
VijayKumar Garg India 8 70 0.6× 9 0.1× 127 2.4× 26 0.8× 13 246
G Schumacher Sweden 6 173 1.6× 182 3.0× 2 0.0× 34 0.9× 93 2.9× 12 244
Kosuke Joh Japan 6 31 0.3× 12 0.2× 4 0.1× 6 0.2× 10 0.3× 11 106
Rory Breathnach Ireland 6 38 0.4× 6 0.1× 22 0.4× 2 0.1× 6 0.2× 15 108
Berat Ebik Türkiye 6 16 0.1× 4 0.1× 15 0.3× 4 0.1× 21 0.7× 18 76
Axel Enninger Germany 6 36 0.3× 36 0.6× 2 0.0× 19 0.5× 64 2.0× 10 122
Ben Hope United Kingdom 4 135 1.3× 51 0.8× 2 0.0× 3 0.1× 117 3.7× 7 164
Christopher McGrath United Kingdom 5 72 0.7× 16 0.3× 20 0.4× 6 0.2× 7 105
Alexandra N. Donlan United States 7 32 0.3× 6 0.1× 10 0.2× 9 0.2× 23 0.7× 9 192

Countries citing papers authored by Empar Sáinz

Since Specialization
Citations

This map shows the geographic impact of Empar Sáinz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Empar Sáinz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Empar Sáinz more than expected).

Fields of papers citing papers by Empar Sáinz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Empar Sáinz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Empar Sáinz. The network helps show where Empar Sáinz may publish in the future.

Co-authorship network of co-authors of Empar Sáinz

This figure shows the co-authorship network connecting the top 25 collaborators of Empar Sáinz. A scholar is included among the top collaborators of Empar Sáinz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Empar Sáinz. Empar Sáinz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Castro, J., Noemí Manceñido, Marta Calvo, et al.. (2020). P681 Efficacy of vedolizumab for the prevention of postoperative recurrence in Crohn’s disease: Data from clinical practice from the ENEIDA registry. Journal of Crohn s and Colitis. 14(Supplement_1). S554–S555. 2 indexed citations
2.
Casellas, Francesc, Laura Marín, Jordi Guardiola, et al.. (2019). Development and validation of the QUECOMIICAT questionnaire: a tool to assess disease-related knowledge in patients with inflammatory bowel disease. Revista Española de Enfermedades Digestivas. 111(8). 586–592. 7 indexed citations
3.
Rosinach, Mercè, Victòria Gonzalo, Empar Sáinz, et al.. (2017). Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review. Gastroenterología y Hepatología (English Edition). 40(6). 381–387. 12 indexed citations
4.
Rosinach, Mercè, Victòria Gonzalo, Empar Sáinz, et al.. (2017). Escasa eficacia de metronidazol en la erradicación de Blastocystis hominis en pacientes sintomáticos: serie de casos y revisión sistemática de la literatura. Gastroenterología y Hepatología. 40(6). 381–387. 12 indexed citations
5.
Andújar, Xavier, Empar Sáinz, Carme Loras, et al.. (2015). Grado de adecuación de las indicaciones de la colonoscopia en una unidad de acceso abierto. Gastroenterología y Hepatología. 38(5). 313–319. 2 indexed citations
6.
Rosinach, Mercè, María Esteve, Clarisa González, et al.. (2012). Lymphocytic duodenosis: Aetiology and long-term response to specific treatment. Digestive and Liver Disease. 44(8). 643–648. 32 indexed citations
7.
Esteve, María, Uma Mahadevan, Empar Sáinz, et al.. (2011). Efficacy of anti-TNF therapies in refractory severe microscopic colitis. Journal of Crohn s and Colitis. 5(6). 612–618. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026